Marijuana Investors: Time to Load Up on Marijuana Stocks?

Marijuana stock Canopy Growth stock has shown investors that Warren Buffett’s advice to be fearful when others are greedy is as sound as ever.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Remember marijuana stocks? Remember when they were the hot topic of discussion and the star performers? In 2018, cannabis stocks were surging as investors priced in huge growth and potential. Today, times have certainly changed. Investors have gone from talking about the seemingly unlimited potential of marijuana stocks to almost complete silence.

Like some other writers at Motley Fool Canada, I wasn’t a believer back then. Too much was being priced into marijuana stocks far too quickly. Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) stock surged 651% from December 2016 to October 2018. In fact, the sector as a whole saw similar gains. But today, after all the euphoria has faded, marijuana stocks are left in the dust. And I’m paying close attention. But why, you ask?

It all boils down to a few basic investing principles. I will borrow one of Warren Buffett’s quotes to explain.

Warren Buffett has warned us against herd mentality

The investing guru has said, “Attempt to be fearful when others are greedy and greedy when others are fearful.” Back in 2018, investors got greedy with marijuana stocks. Today, the bubble has burst. Investors are now more fearful. The reality of the challenges of the marijuana industry have taken centre stage.

Marijuana stocks are currently out of favour

It is not a big revelation to say that marijuana stocks are out of favour. The marijuana bubble burst long ago. Because of this, their valuations are much more reasonable. Not cheap, just more reasonable. Canopy Growth stock currently trades at a price to sales multiple of 23 times. This is still not cheap but it’s a far cry from multiples of north of 100 times. The stock has tanked more than 62% from its 2018 highs, and is flat for the year.

The buyers for cannabis stocks have thinned out, as evidenced by lower trading volumes on the stocks. While the road ahead will not be an easy one, expectations are finally more realistic.

The marijuana industry is a growing industry with a significant market

Moving away now from investor sentiment, expectations, and valuations, let’s look at the fundamentals.

The market for cannabis and cannabis products remains big. There’s recreational marijuana use, where people use marijuana in a similar fashion to the way they use alcohol. There’s also the market for marijuana from an alternative health perspective. And finally, we have the medical marijuana market. This last one has more hurdles and challenges, but from a medical treatment perspective (i.e. Health Canada approved drugs), marijuana certainly has a future.

The current cannabis market size is a clear indication of the relevance of this market. The bustling black market is also a clear indication of this. Finally, current growth rates are a good indication of what lies ahead. In 2020, one analyst estimates that recreational cannabis sales alone will hit $2.5 billion. This is more than double last year’s number. 2021 sales will likely increase over 60%.

Motley Fool: the bottom line

Cannabis stocks like Canopy Growth stock have really been a volatile roller coaster ride. Today, the stocks are trading much lower than their highs.  The cannabis bubble has decidedly burst. As such. Canopy Growth stock is more attractive today. It at least passes one of Warren Buffett’s tests.

But this cannabis stock has yet to turn a profit, so the road ahead will continue to be risky. We must decide whether the potential reward compensates us for this added risk. At Motley Fool, we aim to help you decide.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »